Director of Early Pipeline & Corporate Strategy

Director of Early Pipeline & Corporate Strategy

Director of Early Pipeline & Corporate Strategy

Remotive

Remotive

Remote

9 hours ago

No application

About

This description is a summary of our understanding of the job description. Click on 'Apply' button to find out more.

Role Description

The Director of Early Pipeline & Corporate Strategy plays a pivotal role in shaping the strategic direction of our Immunology Innovation Program (IIP) and aligning early R&D initiatives with broader corporate objectives. This position also contributes to high-level portfolio strategy, long-term forecasting, and the assessment of business development opportunities. This is a high-visibility, cross-functional role that bridges science and strategy. You’ll work closely with leadership and global stakeholders across R&D, corporate development, clinical, commercial, and finance teams.

  • Build business cases for early IIP opportunities across immunology indications.
  • Provide strategic input into discovery-stage efforts and target prioritization.
  • Integrate IIP portfolio insights into long-range planning and development roadmaps.
  • Develop frameworks to assess translational and commercial potential of early-stage assets.
  • Track competitive landscape and scientific trends to inform early investment decisions.
  • Support portfolio reviews and cross-functional prioritization.
  • Conduct scenario planning and risk/benefit analysis to inform pipeline decisions.
  • Contribute to the company’s strategic planning and long-term corporate vision.
  • Lead valuation and forecasting models across therapeutic areas.
  • Collaborate with commercial and HEOR teams to understand unmet need and opportunity spaces.
  • Work closely with Science, Clinical Development, Regulatory, Business Development, and Finance teams.
  • Contribute to strategic evaluations of external partnerships or acquisition opportunities.
  • Help embed strategic frameworks for consistent, data-driven decision-making.

Qualifications

  • 8–12+ years of experience in biotech/pharma strategy, strategic finance, corporate development, or consulting.
  • Advanced degree in life sciences or an MBA with strong scientific fluency (Immunology background preferred).
  • Experience working with early-stage pipelines and scientific uncertainty.
  • Strong analytical and modeling capabilities with the ability to distill complex inputs into clear recommendations.
  • Strategic thinker with excellent communication and influencing skills.
  • Comfortable operating in a dynamic, cross-functional, and global environment.
  • Proven ability to lead through influence and foster collaboration across diverse teams.

Benefits

  • Competitive compensation and benefits
  • A flexible, inclusive work environment
  • A values-based culture focused on innovation, integrity, and impact